Table 3.
Outcome results in terms of medication adherence among the chronic user subpopulation.
| Study group and periodsa | PDCb, mean (SD) | Days covered, mean (SD) | Difference scorec | Participants (n=5888),n (%) | t test (df)d | P valued | 95% CId | Cohen dd | |||||||||
| Control | |||||||||||||||||
|
|
1 year before | 73.29 (28.3) | 267.50 (103.4) |
|
4368 (74.18) | –2.74 (5886) |
.01 | –3.856 to –0.839 | –0.07 | ||||||||
|
|
1 year after | 77.77 (25.2) | 283.86 (91.8) | 4.48 | 4368 (74.18) |
|
|
|
|
||||||||
| SARA | |||||||||||||||||
|
|
1 year before | 70.53 (29.8) | 257.45 (108.6) |
|
1520 (25.82) |
|
|
|
|
||||||||
|
|
1 year after | 77.26 (25.0) | 282.01 (91.1) | 6.73 | 1520 (25.82) |
|
|
|
|
||||||||
aThe study periods were 1 year before and 1 year after the implementation of SARA (Service Apothecary Respiratory Advice; in Dutch, Service Apotheek Raad en Advies).
bPDC: proportion of days covered.
cThe difference score was calculated as the PDC 1 year after SARA minus 1 year before SARA; values are only reported in the “1 year after” rows.
dStatistics comparing study groups are reported only in the top row of values.